ByrneWallace advise Nuvo Pharmaceuticals (Ireland) DAC (Nuvo Ireland) in relation to its acquisition..
ByrneWallace advise Inflazome Limited in relation to its €40 million Series B Financing to develop..
ByrneWallace advised Phibro Animal Health Corporation, a NASDAQ listed global diverse animal health ..
ByrneWallace advised Irish-listed pharmaceutical company Amryt Pharma PLC on an exclusive in-licence..
Acted for Inflazome Limited in connection with its recent Series A financing round for up to €15 m..
Acted for Amryt Pharmaceuticals Designated Activity Company (Amryt DAC) on the reverse takeover of F..